DexCom (DXCM) Earnings Date, Estimates & Call Transcripts → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free DXCM Stock Alerts $125.97 +1.02 (+0.82%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateJul. 25EstimatedActual EPS (Apr. 25) $0.32 Beat By $0.05 Consensus EPS (Apr. 25) $0.27 Read Call TranscriptListen to Call Get DexCom Earnings AlertsEnter your email address below to receive the latest news and earnings results for DXCM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDXCM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DXCM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… DexCom Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.25$0.33$0.28 Q2 20243$0.34$0.45$0.39 Q3 20243$0.39$0.53$0.47 Q4 20243$0.42$0.53$0.48 FY 202412$1.40$1.84$1.63 Q1 20252$0.37$0.37$0.37 Q2 20253$0.47$0.55$0.52 Q3 20251$0.67$0.67$0.67 Q4 20252$0.69$0.73$0.71 FY 20258$2.20$2.32 $2.27DXCM Earnings Date and InformationDexCom last announced its earnings results on April 25th, 2024. The medical device company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $921 million for the quarter, compared to analyst estimates of $911.20 million. DexCom has generated $1.55 earnings per share over the last year ($1.55 diluted earnings per share) and currently has a price-to-earnings ratio of 81.3. Earnings for DexCom are expected to grow by 25.28% in the coming year, from $1.78 to $2.23 per share. DexCom has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off prior year's report dates.Read More DexCom Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/25/2024Estimated)------- 4/25/2024Q1 2024$0.27$0.32+$0.05$0.28$911.20 million$921.00 million 2/8/2024Q4 2023$0.43$0.50+$0.07$0.38$1.02 billion$1.03 billion 10/26/2023Q3 2023$0.34$0.50+$0.16$0.71$939.64 million$975.00 million 7/27/2023Q2 2023$0.22$0.34+$0.12$0.40$841.16 million$871.30 million 4/27/2023Q1 2023$0.15$0.17+$0.02$0.22$720.52 million$7.45 billion 2/9/2023Q4 2022$0.26$0.34+$0.08$0.46$814.52 million$815.20 million Get the Latest News and Ratings for DXCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q3 2022$0.24$0.28+$0.04$0.32$752.67 million$769.60 million7/28/2022Q2 2022$0.17$0.17-$0.22$709.33 million$696.20 million 4/28/2022Q1 2022$0.1250$0.08($0.0450)($0.29)$623.97 million$628.80 million 2/10/2022Q4 2021$0.2150$0.17($0.0450)$1.56$698.66 million$698.20 million 10/28/2021Q3 2021$0.1550$0.2225+$0.0675$1.07$617.07 million$650.20 million 7/29/2021Q2 2021$0.1075$0.19+$0.0825$0.89$548.02 million$595.10 million DexCom Earnings - Frequently Asked Questions When is DexCom's earnings date? DexCom has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates. Learn more on DXCM's earnings history. Did DexCom beat their earnings estimates last quarter? In the previous quarter, DexCom (NASDAQ:DXCM) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.27 by $0.05. Learn more on analysts' earnings estimate vs. DXCM's actual earnings. How can I listen to DexCom's earnings conference call? The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call How can I read DexCom's conference call transcript? The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript How much revenue does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded annual revenue of $3.62 billion. How much profit does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded net income of $541.50 million. DXCM has generated $1.55 earnings per share over the last four quarters. What is DexCom's price-to-earnings ratio? DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 81.27 and a forward price-to-earnings ratio of 70.77. The price/earnings-to-growth ratio is 2.17. What is DexCom's EPS forecast for next year? DexCom's earnings are expected to grow from $1.78 per share to $2.23 per share in the next year, which is a 25.28% increase. More Earnings Resources from MarketBeat Related Companies: 3M Earnings Results Becton, Dickinson and Company Earnings Results ResMed Earnings Results Baxter International Earnings Results Insulet Earnings Results Teleflex Earnings Results NovoCure Earnings Results Boston Scientific Earnings Results Stryker Earnings Results West Pharmaceutical Services Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:DXCM) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon to Transform U.S. Economy? Porter & CompanyThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.